Medico Remedies Ltd. (MEDICO) Remedies 52 Week Low Streak: Why the Stock Keeps Weakening

Medico Remedies Ltd. has now traded within 2% of its 52-week low for its second straight session, with the stock moving down 3.29% across the streak so far. At 12:22 PM IST on 22 October 2026, the stock was trading at Rs 20.59 after touching an intraday low of Rs 20.59. The latest Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.

Against the previous close of Rs 20.8, the share price was down Rs 0.21, or 1.01%, while the day opened and also touched its high at Rs 21.1 before slipping to the low of Rs 20.59. The company’s market capitalisation stood at Rs 172.61 crore, which places the move in a small-cap style price band even as the repeated-low pattern matters more than a single-day dip for readers tracking the Medico Remedies 52 Week Low Streak.

Medico Remedies 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 20.59
Previous Close	Rs 20.8
Today's Move	Rs -0.21 (-1.01%)
Open	Rs 21.1
High	Rs 21.1
Low	Rs 20.59
Market Capitalisation	Rs 172.61 crore

Medico Remedies Ltd. (MEDICO) traded at Rs 20.59 versus the previous close of Rs 20.8, a fall of 1.01%. The stock opened at Rs 21.1, reached a high of Rs 21.1, touched a low of Rs 20.59.

Medico Remedies share price today stayed under pressure through the morning trade, with the current price sitting at the lower end of the visible range after the stock opened at Rs 21.1 and briefly matched that level as the high. The move from the previous close of Rs 20.8 to Rs 20.59 shows a modest decline in the session, but the larger point is that the stock has remained close to its one-year trough for two sessions in a row. That is what keeps the Medico Remedies 52 Week Low Streak in focus.

The day’s range was narrow and tilted to the downside, with Rs 20.59 marking both the current price and the low for the period shown here. For investors scanning Medico Remedies Stock News, the immediate signal is not a sharp one-session shock but a repeated drift near the yearly low. The market capitalisation of Rs 172.61 crore keeps the discussion centred on price weakness, valuation and business fundamentals rather than any intraday rebound narrative. In the context of Medico Remedies Share Price Today, the repeated-low pattern is the more important reading than the day’s small percentage move alone.

What the Repeated 52-Week Lows Show

The Medico Remedies 52 Week Low Streak shows that the stock is not only near its one-year low once, but is staying in that zone across consecutive sessions. With a cumulative decline of 3.29% over the streak, the pattern suggests a persistent decline in the share price rather than a one-off slip. That is useful for readers following Medico Remedies Stock Performance, because repeated weakness can matter more than a single session’s percentage change when the stock is already trading near the bottom of its yearly range.

The latest Univest reading confirms the near 52-week low pattern, but it does not confirm why the stock is holding near that level. So the cleanest interpretation is factual: the market has kept the share near its one-year low for a second straight session, and the current price remains close to the recent low of the day. For search intent around Medico Remedies New One Year Low and Medico Remedies Back To Back 52 Week Lows, the key takeaway is the repeated nature of the move, not a new narrative about the business.

Medico Remedies Ltd. (MEDICO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 172.61 crore
P/E Ratio	12.49x
P/B Ratio	2.21x
ROE	19.02%
ROCE	23.28%
EPS	Rs 1.66
Book Value Per Share	Rs 9.4
Dividend Yield	0%

Medico Remedies Ltd. (MEDICO) fundamental metrics show P/E 12.49x, P/B 2.21x, ROE 19.02%, ROCE 23.28%. These figures provide context only and are not a buy or sell signal.

Medico Remedies Ltd. has a market capitalisation of Rs 172.61 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 12.49x, P/B at 2.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.02% and ROCE of 23.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.66, book value per share of Rs 9.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.02x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	12.49x
Benchmark Median P/E	27.02x
Benchmark Average P/E	38.91x
Benchmark P/E Range	0x to 616.23x
Company P/B Ratio	2.21x
Benchmark Median P/B	2.7x
Company ROE	19.02%
Benchmark Median ROE	11.23%
Company ROCE	23.28%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 172.61 crore
Benchmark Median Market Cap	Rs 786.06 crore

Medico Remedies Ltd. (MEDICO) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 12.49x, which is below the benchmark median of 27.02x, a difference of -53.77%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Medico Remedies Ltd. (MEDICO) has a ROE of 19.02%, which is above the benchmark median of 11.23%, a difference of +69.37%. Medico Remedies Ltd. (MEDICO) has a ROCE of 23.28%, which is above the benchmark median of 13.17%, a difference of +76.77%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Oxygenta Pharmaceutical Ltd.	OXYGENTAPH	174.53	0	-3.9	0	-33.53
Natural Capsules Ltd.	NATCAPSUQ	168.14	0	0.76	-10.89	-4.85
Syschem (India) Ltd.	SYSCHEM	183.2	29.81	1.29	0.7	1.45
Coral Laboratories Ltd.	CORALAB	183.72	9.57	0.86	12.76	17.04
Kerala Ayurveda Ltd.	KERALAYUR	190.44	0	-9.11	-86.43	-8.94

Medico Remedies Ltd. (MEDICO) has a P/E ratio of 12.49x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.02% compares with a peer median of 0% across the companies shown in the table. ROCE stood at 23.28% versus the displayed peer median of -4.85%, providing a capital-efficiency comparison. Medico Remedies Ltd. (MEDICO) has a market capitalisation of Rs 172.61 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching

• The Medico Remedies 52 Week Low Streak has now extended into a second straight session, keeping the yearly low zone in focus for traders and long-term readers.
• The cumulative move across the streak is down 3.29%, which gives a better picture of the repeated weakness than a single-session percentage change.
• The company’s P/E of 12.49 sits below the industry median of 27.02, so valuation is part of the discussion even as the share price remains weak.
• ROE of 19.02% and ROCE of 23.28% are stronger than the industry medians, which makes the price behaviour more important to monitor alongside fundamentals.
• Investors tracking Medico Remedies Company News will want to watch whether the stock stays near its one-year low or starts moving away from that band.

About the Company

Medico Remedies Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company’s market capitalisation is Rs 172.61 crore, placing it in a smaller-company bracket relative to the wider peer universe used here. Its current numbers show P/E at 12.49, P/B at 2.21, ROE at 19.02%, ROCE at 23.28%, EPS at Rs 1.66 and book value at Rs 9.4. For readers following Medico Remedies Share Price updates, these are the core figures that frame the stock’s ongoing price pattern.

The presence of a dividend yield of 0 means the investment case is not being supported by income payout. Instead, the market is evaluating the company through price, earnings and balance-sheet-linked metrics. That is why the Medico Remedies 52 Week Low Streak needs to be read as both a market pattern and a valuation exercise, rather than as a stand-alone chart event.

Frequently Asked Questions

Why is Medico Remedies still near its 52-week low?

Ans. Univest data shows the stock has traded within 2% of its 52-week low for a second straight session. The data confirms the pattern, but it does not identify a company-specific cause for the repeated weakness.

What is the cumulative move across the streak?

Ans. The stock has declined 3.29% across the streak so far. That cumulative figure is more informative than a single session’s move when the price is already close to the yearly low.

How did Medico Remedies trade during the current session?

Ans. The stock last traded at Rs 20.59, compared with the previous close of Rs 20.8. It opened at Rs 21.1, touched a high of Rs 21.1 and a low of Rs 20.59.

Is Medico Remedies expensive compared with its industry peers?

Ans. Its P/E of 12.49 is below the industry median of 27.02 and its P/B of 2.21 is also below the industry median of 2.7. That places the stock below the central valuation benchmark for the sector.

What do the return ratios indicate?

Ans. ROE stands at 19.02% and ROCE at 23.28%, both above the industry medians in the supplied comparison set. Those numbers indicate stronger return ratios than many peers, even as the share price stays weak.

Should investors treat the repeated low pattern as a warning sign?

Ans. The repeated low pattern is a warning flag for price behaviour, not a recommendation. Investors should monitor whether the stock keeps trading near its one-year low and how that aligns with fundamentals and valuation.

What should readers track next in Medico Remedies stock news?

Ans. Readers should track the price pattern, changes in the one-year low zone, and any fresh company information that may affect valuation. The latest data confirms weakness, but not the cause behind it.

Track Medico Remedies Ltd. (MEDICO) Share Price on Univest

Use Medico Remedies Ltd. (MEDICO) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.